Gene · 90
Papers2,859
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 2,859
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Recapitulation of pro-inflammatory signature of monocytes with ACVR1A mutation using FOP patient-derived iPSCs. | Orphanet J Rare Dis | 2022 | 36131296 | PubTator, text mining | PubMed |
| Editorial: TGF-β and BMP signaling in cancer. | Front Cell Dev Biol | 2022 | 36120575 | PubTator, text mining | PubMed |
| Metformin suppresses proliferation and differentiation induced by BMP9 via AMPK signaling in human fetal lung fibroblast-1. | Front Pharmacol | 2022 | 36091775 | PubTator, text mining | PubMed |
| Pediatric glioblastoma cells are sensitive to drugs that inhibit eIF2α dephosphorylation and its phosphomimetic S51D variant. | Front Oncol | 2022 | 36091130 | PubTator, text mining | PubMed |
| Targeted therapy for pediatric diffuse intrinsic pontine glioma: a single-center experience. | Ther Adv Med Oncol | 2022 | 36090803 | PubTator, text mining | PubMed |
| Investigating the Retained Inhibitory Effect of Cobimetinib against p.P124L Mutated MEK1: A Combined Liquid Biopsy and in Silico Approach. | Cancers (Basel) | 2022 | 36077693 | PubTator, text mining | PubMed |
| Analyzing protein conjugation reactions for antibody-drug conjugate synthesis using polarized excitation emission matrix spectroscopy. | Biotechnol Bioeng | 2022 | 36071600 | PubTator, text mining | PubMed |
| Fibrodysplasia ossificans progressiva in Brazil: challenges and strategies to create assistance and educational networks. | Orphanet J Rare Dis | 2022 | 36071499 | PubTator, text mining | PubMed |
| Circulating tumor DNA sequencing provides comprehensive mutation profiling for pediatric central nervous system tumors. | NPJ Precis Oncol | 2022 | 36068285 | PubTator, text mining | PubMed |
| Big data in basic and translational cancer research. | Nat Rev Cancer | 2022 | 36064595 | PubTator, text mining | PubMed |
| Rapid Progression of Heterotopic Ossification in Severe Variant of Fibrodysplasia Ossificans Progressiva with p.Arg258Gly in ACVR1: A Case Report and Review of Clinical Phenotypes. | Case Rep Genet | 2022 | 36060212 | PubTator, text mining | PubMed |
| Intra-pulpal connective tissue formation and the advanced carious lesion: Is chondrogenesis and heterotopic ossification a response to pulpal inflammation? | Int Endod J | 2022 | 36056458 | PubTator, text mining | PubMed |
| Safety and efficacy of jaktinib in the treatment of Janus kinase inhibitor-naïve patients with myelofibrosis: Results of a phase II trial. | Am J Hematol | 2022 | 36054786 | PubTator, text mining | PubMed |
| AI protein structure prediction-based modeling and mutagenesis of a protostome receptor and peptide ligands reveal key residues for their interaction. | J Biol Chem | 2022 | 36049520 | PubTator, text mining | PubMed |
| Quantification of spatial subclonal interactions enhancing the invasive phenotype of pediatric glioma. | Cell Rep | 2022 | 36044867 | PubTator, text mining | PubMed |
| Non-coding RNAs in skin cancers:Biological roles and molecular mechanisms. | Front Pharmacol | 2022 | 36034860 | PubTator, text mining | PubMed |
| Plasma exosomal DOK3 reflects immunological states in lung tumor and predicts prognosis of gefitinib treatment. | Cancer Sci | 2022 | 36028467 | PubTator, text mining | PubMed |
| The Kinesin Gene KIF26B Modulates the Severity of Post-Traumatic Heterotopic Ossification. | Int J Mol Sci | 2022 | 36012474 | PubTator, text mining | PubMed |
| microRNA Expression Profile of Purified Alveolar Epithelial Type II Cells. | Genes (Basel) | 2022 | 36011331 | PubTator, text mining | PubMed |
| Brain Tumor Characterization Using Radiogenomics in Artificial Intelligence Framework. | Cancers (Basel) | 2022 | 36011048 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/90/papers?page=27